Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

BACKGROUND AND AIM: Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Kim, Jihye, Sinn, Dong-Hyun, Choi, Moon Seok, Kang, Wonseok, Gwak, Geum-Youn, Paik, Yong-Han, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405107/
https://ncbi.nlm.nih.gov/pubmed/30845192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0213547
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires